UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial: Reviews in hematologic malignancies

Frontiers in oncology, 2022-12, Vol.12, p.1105523-1105523

2022

Volltextzugriff (PDF)

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation

Frontiers in oncology, 2022-03, Vol.12, p.863800-863800

2022

Volltextzugriff (PDF)

BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study

Haematologica (Roma), 2024-03, Vol.109 (3), p.988-993

2024

Volltextzugriff (PDF)

The Time Has Come for Targeted Therapies for AML: Lights and Shadows

Oncology and therapy, 2020-06, Vol.8 (1), p.13-32

2020

Volltextzugriff (PDF)

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

Oncotarget, 2018-01, Vol.9 (3), p.3379-3393

2018

Volltextzugriff (PDF)

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?

Cells (Basel, Switzerland), 2022-02, Vol.11 (4), p.606

2022

Volltextzugriff (PDF)

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Journal of hematology and oncology, 2019-04, Vol.12 (1), p.44-44, Article 44

2019

Volltextzugriff (PDF)

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Transplantation and cellular therapy, 2021-03, Vol.27 (3), p.244.e1-244.e8

2021

Volltextzugriff (PDF)

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

Clinical hematology international, 2019, Vol.1 (2), p.85-93

2019

Volltextzugriff (PDF)

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B‐LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2023-08, Vol.7 (S3), p.e9701805-n/a

2023

Volltextzugriff (PDF)

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

Journal of hematology and oncology, 2016-09, Vol.9 (1), p.79-79, Article 79

2016

Volltextzugriff (PDF)

PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER TREATMENT WITH VENETOCLAX/HYPOMETHYLATING AGENTS

HemaSphere, 2023-08, Vol.7 (S3), p.e1610525

2023

Volltextzugriff (PDF)

Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation

Clinical hematology international, 2021-12, Vol.3 (4), p.161-168

2021

Volltextzugriff (PDF)

Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently

Clinical hematology international, 2021-12, Vol.3 (4), p.153-160

2021

Volltextzugriff (PDF)

Focus on: Prognostic scores to predict stem cell mobilization

Transfusion and apheresis science, 2024-06, Vol.63 (3), p.103935-103935, Article 103935

2024

Volltextzugriff (PDF)

Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure

Cancers, 2022-09, Vol.14 (17), p.4315

2022

Volltextzugriff (PDF)

P-351 Single vs Tandem Transplant in High-Risk Multiple Myeloma Patients: A Real-Life Single-Centre Analysis

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S235-S236

2024

Volltextzugriff (PDF)

Severe COVID‐19 in a patient with chronic graft‐versus‐host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib

Transplant infectious disease, 2021-02, Vol.23 (1), p.e13401-n/a

2021

Volltextzugriff (PDF)

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

Blood, 2023-11, Vol.142 (Supplement 1), p.4275-4275

2023

Volltextzugriff (PDF)

BCL-2 and BCL-XL Antagonists for the Treatment of Relapsed and Refractory Adult Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. a Campus ALL Real-Life Study

Blood, 2022-11, Vol.140 (Supplement 1), p.8979-8980

2022

Volltextzugriff (PDF)

Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature

Bone marrow transplantation (Basingstoke), 2021-12, Vol.56 (12), p.3081-3083

2021

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Humans
(23)
Hematology
(16)
Male
(14)
Oncology
(14)
Female
(13)
Middle Aged
(13)
Acute Myeloid Leukemia
(11)
Aged
(10)
Immunology
(10)
Stem Cells
(10)
Transplantation
(10)
Adult
(9)
Leukemia
(7)
Life Sciences
(7)
Retrospective Studies
(7)
Stem Cell Transplantation
(7)
Cell Biology
(6)
Hematopoietic Stem Cell Transplantation - Methods
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Editorial: Reviews in hematologic malignancies

Editorial: The Elephant in the Room: AML Relapse After Allogeneic Hematopoietic Cell Transplantation

BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease

Outcome of adult acute myeloid leukemia patients with extramedullary disease and treatment with venetoclax / hypomethylating agents

The Time Has Come for Targeted Therapies for AML: Lights and Shadows

Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission

Autologous Stem Cell Transplantation in Multiple Myeloma: Where Are We and Where Do We Want to Go?

Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia

P375: INOTUZUMB OZOGAMICIN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED OR REFRACTORY ACUTE B‐LYMPHOBLASTIC LEUKEMIA

Matched and mismatched unrelated donor compared to autologous stem cell transplantation for acute myeloid leukemia in first complete remission: a retrospective, propensity score-weighted analysis from the ALWP of the EBMT

PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WITH EXTRAMEDULLARY DISEASE AFTER TREATMENT WITH VENETOCLAX/HYPOMETHYLATING AGENTS

Thiotepa‐busulfan‐fludarabine Compared to Treosulfan‐based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMT

Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation

Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently

Focus on: Prognostic scores to predict stem cell mobilization

Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure

P-351 Single vs Tandem Transplant in High-Risk Multiple Myeloma Patients: A Real-Life Single-Centre Analysis

Severe COVID‐19 in a patient with chronic graft‐versus‐host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib

Late Hematologic Recovery after CPX-351 Induction Chemotherapy in AML: Predictive Disease and Patient's Factors and Their Impact on Survival

BCL-2 and BCL-XL Antagonists for the Treatment of Relapsed and Refractory Adult Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma. a Campus ALL Real-Life Study

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score

Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature

Suchergebnisse filtern